Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 387Neoplasms 333Prostatic Neoplasms 188Lung Neoplasms 175Colorectal Neoplasms 142Motor Activity 87Pancreatic Neoplasms 73Uterine Cervical Neoplasms 70Brain Neoplasms 69Head and Neck Neoplasms 67Carcinoma, Non-Small-Cell Lung 63Ovarian Neoplasms 59Rectal Neoplasms 49Carcinoma, Hepatocellular 49Colonic Neoplasms 46Glioblastoma 42Anxiety Disorders 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Depression 39Neoplasm Metastasis 38Hematologic Neoplasms 37Melanoma 34Glioma 34Multiple Myeloma 33Disease 33Stomach Neoplasms 32Sarcoma 31Carcinoma, Renal Cell 30Urinary Bladder Neoplasms 29Pain 28

Interventions

Tacrolimus 1Sirolimus 1Infliximab 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Kidney Transplantation × 90 days × Clear all
NCT02711202 2026-04-13

Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation

Institute for Clinical and Experimental Medicine

Phase NA Completed
20 enrolled 11 charts
Genitourinary

Kidney Transplantation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡